Healthcare provider profile · identity verified

Gerald A Fulton, MD

Family Practice · BURTON, MI · NPI 1891897633

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	617	211
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	301	66
Levothyroxine Sodium	Levothyroxine Sodium	237	69
Omeprazole	Omeprazole	216	74
Lisinopril	Lisinopril	191	64
Amlodipine Besylate	Amlodipine Besylate	190	72
Losartan Potassium	Losartan Potassium	178	59
Metoprolol Succinate	Metoprolol Succinate	159	53
Metformin Hcl	Metformin Hcl	151	51
Tamsulosin Hcl	Tamsulosin Hcl	144	42
Eliquis	Apixaban	132	33
Metoprolol Tartrate	Metoprolol Tartrate	127	48
Gabapentin	Gabapentin	114	40
Clopidogrel	Clopidogrel Bisulfate	110	34
Prednisone	Prednisone	107	71
Pantoprazole Sodium	Pantoprazole Sodium	85	30
Finasteride	Finasteride	81	23
Potassium Chloride	Potassium Chloride	80	23
Diclofenac Sodium	Diclofenac Sodium	78	44
Furosemide	Furosemide	74	23
Simvastatin	Simvastatin	72	24
Rosuvastatin Calcium	Rosuvastatin Calcium	71	25
Hydrochlorothiazide	Hydrochlorothiazide	70	20
Tramadol Hcl	Tramadol Hcl	69	20
Fluticasone Propionate	Fluticasone Propionate	68	36
Alprazolam	Alprazolam	67	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	24
Duloxetine Hcl	Duloxetine Hcl	64	24
Allopurinol	Allopurinol	63	19
Diazepam	Diazepam	62	25
Glimepiride	Glimepiride	60	23
Famotidine	Famotidine	59	27
Sertraline Hcl	Sertraline Hcl	59	22
Morphine Sulfate Er	Morphine Sulfate	55	suppressed
Atenolol	Atenolol	54	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	23
Fentanyl	Fentanyl	53	suppressed
Oxycodone Hcl	Oxycodone Hcl	49	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	43
Trazodone Hcl	Trazodone Hcl	47	20
Xarelto	Rivaroxaban	47	15
Amitriptyline Hcl	Amitriptyline Hcl	46	16
Carvedilol	Carvedilol	46	16
Ezetimibe	Ezetimibe	45	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	18
Pravastatin Sodium	Pravastatin Sodium	43	15
Ropinirole Hcl	Ropinirole Hcl	42	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	12
Methylprednisolone	Methylprednisolone	38	35
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Jardiance	Empagliflozin	37	15
Montelukast Sodium	Montelukast Sodium	37	13
Oxybutynin Chloride Er	Oxybutynin Chloride	37	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	14
Ozempic	Semaglutide	35	suppressed
Ketoconazole	Ketoconazole	34	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	12
Pioglitazone Hcl	Pioglitazone Hcl	30	12
Alendronate Sodium	Alendronate Sodium	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Azithromycin	Azithromycin	24	23
Bumetanide	Bumetanide	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Tadalafil	Tadalafil	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	21	15
Nitroglycerin	Nitroglycerin	21	17
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	14
Nifedipine Er	Nifedipine	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	14
Fluconazole	Fluconazole	17	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Cephalexin	Cephalexin	16	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Clobetasol Propionate	Clobetasol Propionate	15	11
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Primidone	Primidone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin	Amoxicillin	11	11
Humira Pen	Adalimumab	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error